Full marks for medication transparency
Forward-looking statements in this press release include, without limitation, statements regarding the promise and potential impact of our product candidates, including Revitas potential for preserving weight loss after GLP-1 drug discontinuation
69 Elevations of a kidney injury marker should not come as a surprise, however, as acute kidney injury evaluation in the form of serum creatinine is included in scoring systems such as the APACHE II and KCH criteria
Originally, GLP-1 therapies called for daily, or even twice a day injections
Since background BMI can be largely different between races, caution is needed when interpreting and applying the results, including combination use with SGLT2is and finerenone
Hammerich L, Tacke F